Magriet Raxworthy

Magriet Raxworthy is the chief executive of Dietitians Australia, an organization that advocates for the role of dietitians in health care. In a recent news article, she emphasized the significance of semaglutide, known as Wegovy, highlighting that patients experience substantial health benefits when prescribed this medication in conjunction with dietetic support. Raxworthy has called for safeguards to ensure that individuals receiving weight-loss medications are also provided access to professional dietary guidance, addressing concerns about potential risks such as malnutrition and disordered eating.